Phytoestrogens are potent inhibitors of estrogen sulfation: Implications for breast cancer risk and treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1779-1787

  Harris, R M ^a   Wood, D M ^a   Bottomley, L ^a   Blagg, S ^a   Owen, K ^a   Hughes, P J ^a   Waring, R H ^a   Kirk, C J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYFLAVONE; 3',4' DIHYDROXYFLAVONE; 3,6 DIHYDROXYFLAVONE; 3,7 DIHYDROXYFLAVONE; 6 HYDROXYFLAVONE; 6 HYDROXYFLAVONONE; 7 HYDROXYFLAVONE; 7,8 DIHYDROXYFLAVONE; APIGENIN; ARYL SULFOTRANSFERASE; BAICALEIN; CEREBROSIDE SULFATASE; CHRYSIN; DAIDZEIN; DAIDZEIN 4,7 BISULFATE; EQUOL; ESTROGEN; ESTROGEN SULFOTRANSFERASE; FLAVONOID; GALANGIN; GENISTEIN; ISOFLAVONE; MONOAMINE PHENOLSULFOTRANSFERASE; NARINGENIN; PHYTOESTROGEN; PRIMULETIN; STERYL SULFATASE; SULFATASE; SULFOTRANSFERASE; SULFOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; BREAST CANCER; CANCER RISK; CONCENTRATION RESPONSE; CONJUGATION; DIET; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME STABILITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; METABOLITE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; SULFATION; THERMOSTABILITY; TISSUE;

ARYLSULFOTRANSFERASE; BLOOD PLATELETS; BREAST NEOPLASMS; CELL LINE; CEREBROSIDE-SULFATASE; ESTROGENS; FLAVONOIDS; HUMANS; ISOFLAVONES; LIVER; PHYTOESTROGENS; PLANT PREPARATIONS; PROTEIN ISOFORMS; RISK FACTORS; STERYL-SULFATASE; SUBSTRATE SPECIFICITY; SULFATASES; SULFATES; SULFOTRANSFERASES;

EID: 1942472986     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031631     Document Type: Article

References (56)

1. Muir C, Waterhouse J, Mack T, Powell J, Whelan S 1987 Cancer Incidence in Five Continents. Vol V. Oxford, UK: Oxford University Press
2. Hill MJ 1995 Diet and cancer: a review of scientific evidence. Eur J Cancer Prev 4(Suppl 2):3-42
3. Adlercreutz H 2002 Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83:113-118
4. King A, Young G 1999 Characteristics and occurrence of phenolic phytochemicals. J Am Diet Assoc 99:213-218
5. Adlercreutz H, Markkanen H, Watanabe S 1993 Plasma concentrations of phytooestrogens in Japanese men. Lancet 342:1209-1210
6. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJC, Morgan MRA, Williamson G 1998 Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 436:71-75
7. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka Y, Kubota Y, Kikuchi M 2000 Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130:1695-1699
8. Galijatovic A, Otake Y, Walle UK, Walle T 1999 Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica 29:1241-1256
9. Vaidyanathan JB, Walle T 2002 Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos 30:897-903
10. Adlercreutz H, van der Wildt J, Kinzel J, Attala H, Wähälä K, Mäkelä T, Hase T, Fotsis T 1995 Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52:97-103
11. Glatt H, Boeing H, Engelke CEH, Ma L, Kuhlow A, Pabel U, Pomplun D, Teubner W, Meinl W 2001 Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 482:27-40
12. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM 2001 Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11:57-68
13. Middleton Jr E, Kandaswami C, Theoharides TC 2000 The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751
14. Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ 2001 Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans 29:209-216
15. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118
16. Purohit A, Singh A, Reed MJ 1999 Regulation of steroid sulphatase and oestradiol 17 β-hydroxysteroid dehydrogenase in breast cancer. Biochem Soc Trans 27:323-327
17. Santen RJ, Leszczynski D, Tilson-Mallet N, Feil PD, Wright C, Manni A, Santner SJ 1986 Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann NY Acad Sci 464:126-137
18. Pasqualini JR, Chetrite G, Blacker C, Feinstein M-C, Delalonde L, Talbi M, Maloche C 1996 Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81:1460-1464
19. Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini JR 2000 Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72:23-27
20. Hernandez JS, Watson RW, Wood TC, Weinshilboum RM 1992 Sulfation of estrone and 17 β-estradiol in human liver. Catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase. Drug Metab Dispos 20:413-422
21. Falany CN, Wheeler J, Oh TS, Falany JL 1994 Steroid sulfation by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 48:369-375
22. Falany JL, Falany CN 1996 Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56:1551-1555
23. Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H 2003 Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 63:2762-2770
24. Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T 1996 Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos 24:232-237
25. Kester MH, Bulduk S, van Toor H, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Schuur AG, Brouwer A, Visser TJ 2002 Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142-1150
26. Harris RM, Waring RH, Kirk CJ, Hughes PJ 2000 Sulfation of "estrogenic" alkylphenols and 17β-estradiol by human platelet phenol sulfotransferases. J Biol Chem 275:159-166
27. Hughes PJ, Twist LE, Durham J, Choudhry MA, Drayson M, Chandraratna R, Michell RH, Kirk CJ, Brown G 2001 Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1α,25-dihydroxyvitamin D3. Biochem J 355:361-371
28. Huang Z, Fasco MJ, Kaminsky LS 1997 Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids. J Steroid Biochem Mol Biol 63:9-15
29. Foldes A, Meek JL 1973 Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta 327:365-374
30. Anderson RJ, Weinshilboum RM 1980 Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta 103:79-90
31. Seah VM, Wong KP 1994 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase. Biochem Pharmacol 47:1743-1749
32. Varin L, Barron D, Ibrahim RK 1987 Enzymatic assay for flavonoid sulfotransferase. Anal Biochem 161:176-180
33. Qian Y, Deng C, Song WC 1998 Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. J Pharmacol Exp Ther 286:555-560
34. Baum H, Dodgson KS, Spencer B 1958 The anomalous kinetics of arylsulphatase A of human tissues: the anomalies. Biochem J 69:567-572
35. Weinshilboum RM 1986 Phenol sulfotransferase in humans: properties, regulation, and function. Fed Proc 45:2223-2228
36. Uehar M, Arai Y, Watanabe S, Adlercreutz H 2000 Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors 12:217-225
37. Gooderham MH, Adlercreutz H, Ojala ST, Wahala K, Holub BJ 1996 A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 126:2000-2006
38. Coward L, Kirk M, Albin N, Barnes S 1996 Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 247:121-142
39. Erlund I, Silaste ML, Alfthan G, Rantala M, Kesaniemi YA, Aro A 2002 Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr 56:891-898
40. Erlund I, Meririnne E, Alfthan G, Aro A 2001 Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131:235-241
41. Kellis Jr JT, Vickery LE 1984 Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225:1032-1034
42. Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, Arosemena PJ, Kellis Jr JT, Vickery LE 1993 Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44:147-153
43. Le Bail JC, Champavier Y, Chulia AJ, Habrioux G 2000 Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 66:1281-1291
44. Makela S, Poutanen M, Kostian ML, Lehtimaki N, Strauss L, Santti R, Vihko R 1998 Inhibition of 17β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 217:310-316
45. Wong CK, Keung WM 1999 Bovine adrenal 3β-hydroxysteroid dehydrogenase (E. C. 1.1.1.145)/5-ene-4-ene isomerase (E. C. 5.3.3.1): characterization and its inhibition by isoflavones. J Steroid Biochem Mol Biol 71:191-202
46. Wong CK, Keung WM 1997 Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase. Biochem Biophys Res Commun 233:579-583
47. 3]isoflavone internal standards. Anal Biochem 309:158-172
48. Rowland I, Wiseman H, Sanders T, Adlercreutz H, Bowey E 1999 Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 27:304-308
49. Falany JL, Macrina N, Falany CN 2002 Regulation of MCF-7 breast cancer cell growth by β-estraddol sulfation. Breast Cancer Res Treat 74:167-176
50. Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H 1998 Effect of soy milk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 90:1830-1835
51. Nagata C, Inaba S, Kawakami N, Kakizoe T, Shimizu H 2000 Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 36:14-18
52. Nikander E, Kilkkinen A, Metsa-Heikkila M, Adlercreutz H, Pietinen P, Tiitinen A, Ylikorkala O 2003 A randomized placebo-controlled cross-over trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101:1213-1220
53. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L 1996 Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5:785-794
54. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W 2001 Population-based case-control study of soy food intake and breast cancer risk in Shanghai. Br J Cancer 85:372-378
55. Cornish-Bowden A 1979 Fundamentals of enzyme kinetics. London: Butterworth Co. Ltd.
56. Cortes A, Cascante M, Cardenas ML, Cornish-Bowden A 2001 Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 357:263-268